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James T. Anderson, MD; David A. Ogden, MD; and Thomas E. Starzl, MD, PhD, Denver 
'l'hl'l'e young male patients dl'-
'Veloped acute glomerulonephr-itis 
and sel'ious hemoptysis. All three 
had evidence of antiglomerular 
basement membmne (anti-GBM) 
antibodies in their serum and native 
kidneys. The pulmonary hemorrhages 
ceased after bilateral nephrectomy 
and splenectomy accompanied by ir-
regular treatment with steroids and 
other immunosuppressants. Renal 
homotransplantation was success-
A ntibodies detectable by immu-
nofluorescence and by elution 
react with the glomerular base-
ment membrane producing glomeru-
lar injury.1-S The subsequent glo-
merulonephritis often progresses 
rapidly and, when associated with 
pulmonary hemorrhage (sometimes 
fatal), is properly termed Goodpas-
ture's syndrome.9-11 The pulmonary 
manifestations are presumed to in-
volve cross reaction of the anti-
glomerular basement membrane 
(anti-GBM) antibodies with the 
alveolar septal basement mem-
brane.1,3-5,S,12-25 In patients, many 
of whom were diagnosed on clinical 
grounds only, chronic systemic ster-
oid therapy, other immunosuppres-
sive agents, and hemodialysis have 
been inconsistent or valueless in con-
trolling either these renal or pul-
monary symptoms.ll ,16-22 
This paper reports three patients 
with anti-GBM antibody mediated 
glomerulonephritis and pulmonary 
hemorrhage treated initially with 
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fully carril'd (Jut from. 95 to 162 
days later, after circulating anti-
GBM antibodies had disappeared. 
Two of the homo grafts were biopsied 
and the third was removed 20, 34, 
and 2 months posttmnsplantation, 
respectively, and contained little or 
no immunoglobulin. Therefore, Good-
pasture's syndrome does not con-
traindicate renal transplantation un-
der the stipulated conditions of 
staged therapy. 
splenectomy and bilateral nephrec-
tomy 7 to 37 months ago. After 
circulating anti-GBM antibodies 
could no longer be detected, each 
patient received a renal homograft. 
Methods 
General Care.-The surgical pro-
cedures and the general principles of 
postoperative care have been described 
elsewhere.23 Immunosuppression with 
azathioprine, prednisone, and equine 
antilymphocyte globulin (ALG) 24 was 
begun two to four days before trans-
plantation. The subsequent timing and 
dosage of the individual agents are 
shown in Fig 1 to 3. The recipients' 
ages, the timing of surgical interven-
tions, and the source and match of 
kidney homografts are shown in the 
Table. 
Detection of Renal Bound and Cir-
culating Anti-GBM Antibodies.-Snap 
frozen renal nephrectomized and biop-
sied specimens were examined for 
glomerular-bound human immunoglob-
ulins (IgG, IgA, and IgM), comple-
ment (C3), fibrin, albumin, and equine 
immunoglobulin by direct immuno-
fluorescence.25 Anti-GBM antibodies 
eluted from this renal tissue with hy-
potonic citrate buffer (pH 3.2) were 
detected by indirect immunofluores-
cence on normal human kidney 
sections.7,s Circulating anti-GBM anti-
bodies were sought by indirect im-
munofluorescence using normal human 
kidney sections.26 Preformed cytotoxic 
antibodies against donor lymphocytes 
were ruled out in all three cases by 
the direct cross-match method of 
Terasaki.27 
Report of Cases 
CASE 1.-A 30-year-old white man 
was admitted to the Denver Veterans 
Administration Hospital with a two-
day history of hematuria. Within one 
week he developed hemoptysis, fluffy 
infiltrates throughout both lung fields, 
and oliguria (250 ml/24 hr). A closed 
renal biopsy revealed necrotizing 
glomerulitis. Prednisolone (120 mg/ 
day) did not halt progressive renal 
failure (Fig 1), necessitating hemodi-
alysis; however, the lung fields cleared 
rapidly. He was treated with variable 
daily doses (usually 2 mg/kg/day) of 
mercaptopurine between the 11th and 
30th days following admission. In J an-
uary 1968, 115 days after the onset of 
symptoms, elective splenectomy and 
bilateral nephrectomy were performed. 
A severe, crescent-forming, subacute 
glomerulonephritis was present histo-
logically (Fig 4). Anti-GBM antibod-
ies were present in the kidneys and in 
the circulation. Renal homotransplan-
tation followed after an additional 95 
days when circulating anti-GBM anti-
bodies had disappeared. There were no 
rej ection episodes, and the normally 
functioning homograft was biopsied 
34 months posttransplantation. No 
glomerular abnormalities were present 
by light microscopy (Fig 5) . 
GASE 2.-A 29-year-old white man 
had recurrent "bronchopneumonia" in 
September and October of 1968, asso-
ciated with dyspnea and hemoptysis. 
On Jan 8, 1969, he was hospitalized in 
another city for these pulmonary 
symptoms and gross hematuria. Labo-
ratory studies disclosed the following 
values: hematocrit reading, 20 % ; 
blood urea nitrogen (BUN), 60 mg! 
100 ml; and antistreptolysin titer, 
250 Todd units/100 ml (slightly ele-
vated). Blood pressure was 160/80 mm 
Hg. Despite the maintenance of good 
urinary output, his BUN level rose to 
152 mgl100 ml. 
On Jan 20, 1969, he was admitted to 
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Fig l.--Course of 30-year-old male patient (case 1). 
the Denver Veterans Administration 
Hospital in acute respiratory tract dis-
tress with muscle cramps, chills, trem-
or, and malaise. His blood pressure 
was 142/90 mm Hg and he had 2 + 
pitting pretibial edema. His hemato-
crit reading was 25 0/0; BUN, 170 
mg!100 ml; and serum creatinine, 9.5 
mg/100 ml. Creatinine clearance was 5 
ml!min, and there was microscopic he-
maturia with 3+ albuminuria. Anti-
streptolysin titer was within normal 
limits; antinuclear antibody titers 
(ANA) and three LE preparations 
were negative. An x-ray film of the 
chest demonstrated bilateral intersti-
tial infiltrates. On Jan 23 percutaneous 
renal biopsy revealed a severe, sub-
acute, crescent-forming glomerulone-
phritis. 
Treatment was started with 60 mg 
of prednisone per day_ Hemoptysis 
with inadequate oxygenation persisted, 
and on Feb 4, 1969, bilateral nephrec-
tomy and splenectomy were carried 
out, even though significant renal func-
tion remained (serum creatinine, 13.5 
mg/100 ml; creatinine clearance, 6 
ml/min, BUN, 146 mg/100 ml; and 
daily urine volume of about 900 ml). 
The renal biopsy findings were con-
firmed (Fig 4) with anti-GBM antibod-
ies detected in the nephrectomized 
kidneys and in the circulation (Fig 6 
to 8). 
After surgery, hemodialysis was 
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started and repeated three times a 
week, while the steroid dosage was 
gradually lowered. Hemoptysis re-
curred (Fig 2 and 9) with near death 
from an alveolocapillary diffusion de-
fect. The pulmonary hemorrhage 
ceased with increased dosage of pred-
nisone which was subsequently tapered 
from 105 to 10 mg/day. On July 3, 
1969, a total of 149 days after ne-
phrectomy and splenectomy, after the 
circulating anti-GBM antibodies had 
disappeared, he received a renal homo-
graft from his brother, which has 
functioned normally since (Fig 2). He 
had serum hepatitis, Au-positive, in 
the early posttransplantation period. 
The homograft was biopsied 20 
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Fig 2.-Course of 29-year-old male patient (case 2). 
months after transplantation and no 
glomerular abnormalities were found 
by light microscopy (Fig 5). 
CASE 3.-A 35-year-old white man 
noted anorexia and vomiting as well 
as ankle edema in late May 1970. One 
week later, intermittent hemoptysis 
began with no other pulmonary symp-
toms. His local physician observed 
gross hematuria. Laboratory studies 
revealed the following values: blood 
pressure, 150/100 mm Hg; anemia 
with a hematocrit reading of 33 'j" ; 
BUN, 41 mg/lOO ml; and serum creat-
InIne, 3.1 mg/lOO ml. Urinalysis 
showed 4 + protein, numerous granu-
lar casts, and gross blood. An x-ray 
film of the chest was normal except for 
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prominent bronchovascular marking of 
the hilum of the left lung. 
He was admitted to the Denver Vet-
erans Administration Hospital on July 
1, 1970. The previous laboratory and 
physical findings were confirmed except 
that the hematocrit reading had fallen 
to 25% and the BUN and serum creat-
inine had risen to 85 mg/100 ml and 
15,6 mg/lOO ml, respectively. Rheuma-
toid factor, ANA, and three LE prepa-
rations were negative, and whole 
serum complement was normal. An 
x-ray film of the chest showed bilateral 
lower-lobe alveolar infiltrates. A needle 
biopsy of the kidney revealed acute 
glomerulonephritis with crescent for-
mation. 
Systemic heparinization and furo-
semide therapy were begun on July 3, 
1970. Within three days he became 
oliguric and had severe hemoptysis 
and dyspnea (oxygen pressure [Po2], 
53 mm Hg, while receiving oxygen 
nasally, 4 liters/min). The alveolar 
infiltrates in both lung fields had ex-
tended. Intermittent hemodialysis was 
begun. With the presumptive diagno-
sis of Goodpasture's syndrome, aza-
thioprine and prednisone therapy were 
started, provided no perceptable bene-
fit, and were discontinued. After a 
complicated course during which emer-
gency thoracentesis and periardiocen-
tesis were required, splenectomy and 
bilateral nephrectomy were done on 
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Aug 19, 1970. Severe, crescent-forming 
subacute glomerulonephritis was pres-
ent (Fig 4). Linear immunofluores-
cent deposits of human IgG and C3 
were detected in the nephrectomized 
kidneys, and anti-GEM antibodies 
were present in the circulation. 
A maternal kidney was transplanted 
after 162 days during which circulat-
ing anti-GEM antibodies had disap-
peared. After 18 hours of brisk diure-
sis, an apparent accelerated rejection 
took place with oliguria and azotemia, 
but not proteinuria. Adequate renal 
function returned (Fig 3) after one 
posttransplantation dialysis. 
Results 
Renal Bound and Circulating 
Anti-GBM Antibodies.--All three 
cases had direct immunofluorescent 
evidence of anti-GBM antibodies in 
the native kidneys, with linear de-
posits of IgG and C3 bound to the 
glomerular basement membrane 
(Fig 7). No deposits of IgA, IgM, 
fibrin, or albumin were identified. 
The presence of anti-GBM antibod-
ies reactive with Bowman's capsule 
and to a portion of the tubular 
basement membranes in addition to 
GBM was confirmed by elution 
studies in cases 1 and 2 (Fig 7). 
Lnfortunately, tissue was not avail-
able for elution in case 3. 
Homograft biopsies at 34 months 
(case 1) and 20 months (case 2) 
did not contain unusual human IgG, 
IgA, IgM, fibrin, albumin, or equine 
immunoglobulin deposits. Moderate 
amounts of C3 were present in ves-
sel walls, and trace amounts of ir-
regular C3 deposits were seen in the 
mesangial stalk. 
Circulating anti-GBM antibodies 
were present before or following ne-
phrectomy, or both, in all three 
patients (Fig 8). In case 1, circu-
lating anti-GBM antibodies were 
detected by both indirect immuno-
fluorescence and by fixation to a 
normal infant kidney interposed in 
the patient's arteriovenous dialysis 
shunt 16 days following nephrecto-
my. The anti-GBM antibodies in 
the perfused kidney were detected 
by direct immunofluorescence and 
confirmed by elution studies. Anti-
GBM antibodies absent prior to 
transplantation (95 to 162 days af-
ter bilateral nephrectomy) have not 
recurred. 
Comment 
Subsequent renal transplantation 
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Fig 3.--Course of 35·year-old male patient (case 3), 
Case Material 
Date of onset 
Age of patient, yr 
Date of splenectomy and nephrectomies 
Date of transplantation 
Kidney donor 
Terasaki match 
Time of posttransplantation. mo 
provided long-term success in two 
of these cases. Similar treatment 
has been reported associated with 
favorable rc,.;ults in five additional 
patients with clinical courses com-
patible with Goodpasture's syn-
drome.2s :!1 In view of the limited 
number of patients and the com-
plex therapeutic measures involving 
Case 1 Case 2 Case 3 
10/1/67 9/13/68 5/29/70 
30 29 35 
1/24/68 2/4/69 8/19 70 
4/29/68 7/3/69 1/28/71 
Brother Broth,,, Sister 
A A D 
34 ;:>0 
surgery, anesthesia, dialysis, and 
intensive immunosuppression, it is 
difficult to determine definitely spe-
cific effects of any single measure. 
No doubt multiple fadors influence 
most events, fOI" example, the 
importance of pharmacologie immu-
nosuppression is indicated by the 
exacerbation of hemoptysis folIow-
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Fig 4.-Crescent forming subacute glomerulonephritis found in native kidneys 
of patients in case 1 (lett), case 2 (center), and case 3 (right) (PAS, X340). 
~-
I 
Fig 5.-Normal histologic appearance of representative glomeruli from renal 
homograft biopsies of case 1 (left) 34 months posttransplantation and case 2 
(right) 20 months posttransplantation (PAS, x340). 
Fig 5.-Smooth continuous linear deposits of human IgG found along glomeru-
lar basement membrane (case 2) (fluorescein isothiocyanate-conjugated rabbit anti-
human IgG, X250; inset, Xl,OJO). 
ing reduction in prednisone dose in 
two of our patients. The dramatic 
improvement of pulmonary disease 
following nephrectomy in two of 
our patients is by no means a con-
sistent finding. Further, it is even 
impossible to establish whether dis-
appearance of circulating anti-GEM 
antibodies is an essential prerequis-
i te for successful renal transplan-
tation, but this certainly seems 
likely.7 
There are a number of theoretical 
aspects of the surgery employed 
which led to its application and 
should be considered. At least three 
immunologic consequences of the 
surgery may have had beneficial 
effects. First, splenectomy may re-
duce antibody forming potential, 
thereby contributing to fall in 
anti-GEM antibodies. Second, ne-
phrectomy by eliminating the GEM 
may be removing an antigenic stim-
ulus. Third, nephrectomy by remov-
ing the normal route of excretion of 
non renal basement membrane anti-
gens, which presumably are derived 
from turnover of basement mem-
brane generally and which cross-re-
act with glomerular basement mem-
brane, might cause an increase in 
circulating basement membrane an-
tigens which could combine with 
anti-GEM antibodies, thereby pro-
tecting the lungs.15•32 The postne-
phrectomy improvement of patients 
with little or no residual renal func-
tion could not be attributed to this 
third mechanism. Unfortunately, 
there is no available direct evidence 
Fig 7.-Fixation of human IgG eluted (pH 3.2) from native kidney to normal 
human kidney section (case 2). Fixation is to glomerular basement membrane, 
Bowman's capsule, and to tubular basement membranes (arrows) (fluorescein 
isothiocyanate·conjugated rabbit anti·human IgG, X250). 
Fig B.-Fixation of IgG from immediate postnephrectomy serum of to a normal 
human kidney section (case 2). Fixation is to glomerular basement membrane, 
Bowman's capsule, and tubular basement membranes (arrows) (fluorescein iso· 
thiocyanate·conjugated rabbit anti·human igG, X250). 
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Fig 9.-X·ray films of the chest 19, 
21, and 41 days following bilateral neph· 
rectomy and splenectomy. Diffuse pul· 
monary infiltrate (top) was associated 
with massive hemoptysis and severe 
alveolar·capillary diffusion defect. Two 
days later, after increase in dosage of 
prednisone the hemoptysis diminished, 
diffusion block improved, and infiltrate 
began to clear (center) . Twenty days 
later, x·ray film was normal (bottom) 
and patient was asymptomatic (case 2). 
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if) support any of these lJossibili-
ties; however, de Oliveira et aF;:1 
ohserved in rats that prior termina-
tion of renal excretion greatly less-
ened the pneumotoxic effect of het-
erologous nephrotoxic sera. ThiR 
might have resulted in part from 
increased circulating basement 
membrane antigens or from the 
anti-inflammatory effects of uremia 
or both. A t least two theoretical 
disadvantages associated with ne-
phrectomy did not seem to be im-
portant in these patients. The re-
moval of the GBM did not appear 
to terminate any significant protec-
tive immuno-absorbent action. The 
accumulation, if any, of nonrenal 
basement membrane antigens in the 
circulation did not appear to serve 
as an immunogenic stimulus. 
In the absence of more decisive 
evidence, we have adopted the fol-
lowing policies. Nephrectomy and 
splenectomy are performed follow-
ing stabilization of the clinical 
course with dialysis and steroid 
therapy. Circulating anti-GBM an-
t ibodies are monitored. Immuno-
suppression is not provided during 
the waiting period unless circulat-
ing anti-GBM antibodies persist 
or pulmonary hemorrhage recurs. 
When circulating anti-GBM anti-
bodies disappear, usually within six 
months, renal transplantation may 
proceed. If circulating anti-GBM 
antibody remains, chronic immuno-
suppression should be considered. 
Subsequent to the preparation of 
this paper, the patient in case 3 
de"eloped a staphylococcal wound 
ahscess and severe bilateral bron-
chial pneumonia which led to his 
death S~ days following transplan-
tation. Prior to death, immunosup-
pressive therapy was withdrawn 
and his kidney was removed after 
being in residence for 62 days. 
Postmorten examination revealed 
necTosis and abscess formation in 
both lungs due to infection with 
multiple organisms, including Pseu-
domonas EwruginoK~aI C nlbicans, 
Aspergilll/s, and cytomegalovirus. 
Histologic examination of the ex-
cised homograft revealed scant fo-
cal interstitial mononuclear cell 
accumulation. Focal glomeruiar hy-
percellularity was present with 
some cells containing intranuclear 
indusion bodies. ~ 0 conclusive evi-
dence of anti-GB:.VI antibodies in 
the homograft was found by im-
munofluorescence and acid elution 
Arch Surg/Vol 103, Aug 1971 
studies of the 50 gm of tissue avail-
able for study. 
This investigation was stlPpmted by Public 
Health Service research grants AI-04152. Al-
07007, AI-AM-08898, AM-12148, AM-06344, 
AM-07772, RR-00051, RR-00069, and HE-09110; 
Public Health Service contract PH-43-68-621; 
and Atomic Energy Commission contract 
AT (04-a) -410. 
Elution stuui€'s on cases 1 and 2 were per· 
formed by Richard A. Lerner, MD. and John 
J. McPhaul, Jr., MD, rc"pectively. 
Nonproprietary and 
Trade Names of Drugs 
Aza thioprine--I muran. 
Furosemide-Lasi:x. 
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